103 related articles for article (PubMed ID: 7074585)
1. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy.
Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS
Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585
[TBL] [Abstract][Full Text] [Related]
2. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.
Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G
Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
[TBL] [Abstract][Full Text] [Related]
4. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR
JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584
[TBL] [Abstract][Full Text] [Related]
5. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
7. Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease.
Yau T; Wong H; Chan P; Chan T; Mak J; Epstein RJ
Clin Colorectal Cancer; 2010 Apr; 9(2):108-12. PubMed ID: 20378505
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of serial carcinoembryonic antigen (CEA) determinations in monitoring chemotherapy.
Young VL; Kashmiri R; Hazen ZR; Meeker WR
South Med J; 1976 Oct; 69(10):1274-6. PubMed ID: 982100
[TBL] [Abstract][Full Text] [Related]
9. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
Paulick R; Caffier H
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
[TBL] [Abstract][Full Text] [Related]
12. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
Pompecki R; Schröder G; Garbrecht M; Frahm H
Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
[TBL] [Abstract][Full Text] [Related]
13. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
Lokich JJ; Zamcheck N; Lowenstein MW
Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
[TBL] [Abstract][Full Text] [Related]
14. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
15. The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.
Theriault RL; Hortobagyi GN; Fritsche HA; Frye D; Martinez R; Buzdar AU
Cancer; 1989 Mar; 63(5):828-35. PubMed ID: 2914290
[TBL] [Abstract][Full Text] [Related]
16. Serial tests of carcinoembryonic antigen in patients with breast cancer.
Lee YT
Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patients.
Veronesi A; Talamini R; Longhi S; Crivellari D; Galligioni E; Tirelli U; Trovò MG; Magri MD; Frustaci S; Figoli F; Zagonel V; Tumolo S; Grigoletto E
Tumori; 1982 Dec; 68(6):477-80. PubMed ID: 7168012
[TBL] [Abstract][Full Text] [Related]
18. Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?
Lawrence N; Hinder V; Murray M; Macapagal J; Thompson P; Sharples K; Findlay M
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e124-e131. PubMed ID: 26245738
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma.
Haagensen DE; Kister SJ; Vandevoorde JP; Gates JB; Smart EK; Hansen HJ; Wells SA
Cancer; 1978 Sep; 42(3 Suppl):1512-9. PubMed ID: 709523
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen as a monitor of recurrent breast cancer.
Lee YT
J Surg Oncol; 1982 Jun; 20(2):109-14. PubMed ID: 7078191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
